title: Blockade of preS2 down-regulates the apoptosis of HepG2.2.15 cells induced by TRAIL.
abstract: The TNF-related apoptosis-inducing ligand (TRAIL) has recently been implicated in the death of hepatocytes under infectious but not normal conditions. Our previous studies showed that both the whole HBV genome and its HBx protein enhanced TRAIL-induced hepatocyte apoptosis. We report here that preS2-containing viral proteins are also potent regulators of TRAIL-induced apoptosis. HBV-transfected hepatoma cell line, HepG2.2.15, pretreated with antisense oligonucleotide against preS2 gene, showed a lower sensitivity towards TRAIL-induced apoptosis. However, this effect might not be related with the expression level of TRAIL receptors. These results establish that besides HBx, preS2 viral proteins are also involved in enhancing TRAIL-induced hepatocyte apoptosis. The novel role of preS2 would be useful to further unravel the mechanisms of imbalanced apoptosis during HBV infection and provides a potential therapeutic target for HBV-related diseases.
authors.affiliation: Institute of Immunology, School of Medicine, Shandong University, Jinan 250012, China.
authors.forename: Xiaohong
authors.initials: X
authors.lastname: Liang
authors.forename: Zhonghua
authors.initials: Z
authors.lastname: Qu
authors.forename: Zhiyong
authors.initials: Z
authors.lastname: Zhang
authors.forename: Juan
authors.initials: J
authors.lastname: Du
authors.forename: Yugang
authors.initials: Y
authors.lastname: Liu
authors.forename: Min
authors.initials: M
authors.lastname: Cui
authors.forename: Hua
authors.initials: H
authors.lastname: Liu
authors.forename: Lifen
authors.initials: L
authors.lastname: Gao
authors.forename: Lihui
authors.initials: L
authors.lastname: Han
authors.forename: Suxia
authors.initials: S
authors.lastname: Liu
authors.forename: Lili
authors.initials: L
authors.lastname: Cao
authors.forename: Peiqing
authors.initials: P
authors.lastname: Zhao
authors.forename: Wensheng
authors.initials: W
authors.lastname: Sun
mesh_terms: D017209:Apoptosis / Q000187:drug effects*; D006528:Carcinoma, Hepatocellular / Q000378:metabolism* / Q000473:pathology*; D045744:Cell Line, Tumor; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation / Q000187:drug effects; D006514:Hepatitis B Surface Antigens / Q000378:metabolism*; D006801:Humans; D011498:Protein Precursors / Q000378:metabolism*; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000008:administration & dosage*
chemical_list: D006514:Hepatitis B Surface Antigens; D011498:Protein Precursors; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human; C050807:presurface protein 2, hepatitis B surface antigen